We are live on !
Find out more
Fairman Group Portfolio holdings
AUM
$140M
Turnover
7.54%
1-Year Est. Return
10.49%
This Fund
S&P 500
This Quarter Est. Return
+6.41%
1 Year Est. Return
+10.49%
3 Year Est. Return
+46.82%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$140M
AUM Growth
+$12.4M
(+9.8%)
Cap. Flow
+$6.57M
Cap. Flow % of AUM
Cap. Flow %
4.7%
Top 10 Holdings %
Top 10 Hldgs %
66.24%
Holding
345
New
13
Increased
74
Reduced
17
Closed
13
Avg Time Held
1.9
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Russell 1000 Value ETF
VONV
|
+$1.95M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.81M |
| 3 |
TCW Transform 500 ETF
VOTE
|
+$1.65M |
| 4 |
Strive 500 ETF
STXF
|
+$972K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$654K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamond Hill Large Cap Concentrated ETF
DHLX
|
+$1.18M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$1.09M |
| 3 |
Accenture
ACN
|
+$292K |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$131K |
| 5 |
Vanguard Total World Stock ETF
VT
|
+$97.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.65% |
| 2 | Technology | 13.24% |
| 3 | Financials | 7.6% |
| 4 | Healthcare | 1.46% |
| 5 | Consumer Discretionary | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Exelon
EXC
$47.9B
| $13.8K | 0.01% |
342
| – | – |
2023 Q4
11 quarters
|
|
152
iShares S&P 500 Value ETF
IVE
$51.6B
| $13.2K | 0.01% |
58
| – | – |
2026 Q2
1 quarter
|
|
153
Royal Bank of Canada
RY
$290B
| $12.8K | 0.01% |
65
| – | – |
2025 Q3
4 quarters
|
|
154
Ameriprise Financial
AMP
$45.8B
| $12.3K | 0.01% |
25
| – | – |
2023 Q4
11 quarters
|
|
155
Bank of America
BAC
$356B
| $11.7K | 0.01% |
215
| – | – |
2023 Q4
11 quarters
|
|
156
Honeywell
HON
$72.4B
| $11.3K | 0.01% |
49
+44
| +880% | +$9.8K |
2023 Q4
11 quarters
|
|
157
International Paper
IP
$18.9B
| $11.2K | 0.01% |
337
+4
| +1% | +$153 |
2023 Q4
11 quarters
|
|
158
IBM
IBM
$240B
| $11K | 0.01% |
50
| – | – |
2023 Q4
11 quarters
|
|
159
Schwab Emerging Markets Equity ETF
SCHE
$12.2B
| $10.3K | 0.01% |
282
| – | – |
2026 Q2
1 quarter
|
|
160
Progressive
PGR
$136B
| $9.7K | 0.01% |
+47
| New | +$10.2K |
2026 Q3
0 quarters
|
|
161
VanEck Semiconductor ETF
SMH
$64.6B
| $9.7K | 0.01% |
16
| – | – |
2026 Q1
2 quarters
|
|
162
Vanguard Morningstar Small-Cap ETF
VB
$80B
| $9.6K | 0.01% |
34
| – | – |
2023 Q4
11 quarters
|
|
163
Oracle
ORCL
$375B
| $9.6K | 0.01% |
70
| – | – |
2023 Q4
11 quarters
|
|
164
TotalEnergies
TTE
$199B
| $9.5K | 0.01% |
110
| – | – |
2025 Q3
4 quarters
|
|
165
Cigna
CI
$80.7B
| $9.5K | 0.01% |
35
| – | – |
2023 Q4
11 quarters
|
|
166
Broadcom
AVGO
$1.55T
| $9.48K | 0.01% |
27
| – | – |
2025 Q3
4 quarters
|
|
167
SpaceX
SPCX
$1.85T
| $9.35K | 0.01% |
62
| – | – |
2026 Q2
1 quarter
|
|
168
ASML
ASML
$577B
| $9.06K | 0.01% |
5
+2
| +67% | +$3.47K |
2025 Q3
4 quarters
|
|
169
State Street
STT
$47.2B
| $8.56K | 0.01% |
49
| – | – |
2025 Q4
3 quarters
|
|
170
RB Global
RBA
$17.6B
| $8.38K | 0.01% |
103
| – | – |
2025 Q3
4 quarters
|
|
171
Sony
SONY
$152B
| $8.28K | 0.01% |
352
| – | – |
2025 Q3
4 quarters
|
|
172
RELX
RELX
$71.3B
| $8.23K | 0.01% |
248
| – | – |
2023 Q4
11 quarters
|
|
173
Teva Pharmaceutical Industries Limited
TEVA
$48.8B
| $8.16K | 0.01% |
206
| – | – |
2025 Q3
4 quarters
|
|
174
GE Aerospace
GE
$342B
| $8.12K | 0.01% |
26
+18
| +225% | +$6.24K |
2023 Q4
11 quarters
|
|
175
Lineage Inc
LINE
$8.79B
| $8.07K | 0.01% |
233
+3
| +1% | +$122 |
2026 Q1
2 quarters
|
|
Similar funds
SAM
BIO
BCP
Fairman Group's Q3 2026 Portfolio in Review
As of Q3 2026, Fairman Group held 345 positions worth $140M, up 9.8% from $127M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Fairman Group deployed $6.57M of net new capital in Q3 2026, opening 13 new positions and adding to 74 existing holdings. Its largest new stake was Progressive: 47 shares worth $9.7K.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Diamond Hill Large Cap Concentrated ETF, an estimated $1.18M trimmed.
- Fairman Group's largest Q3 2026 buy was Progressive: 47 shares worth $9.7K.
- Fairman Group added most to Vanguard Russell 1000 Value ETF in Q3 2026, an estimated $1.95M increase.
- Fairman Group's biggest Q3 2026 reduction was Diamond Hill Large Cap Concentrated ETF, cutting an estimated $1.18M.
- Fairman Group fully exited iShares Gold Trust Micro in Q3 2026, selling an estimated $38.4K.
- Fairman Group's ten largest holdings make up 66% of its $140M portfolio in Q3 2026.
- Fairman Group opened 13 new positions and closed 13 in Q3 2026.
- Fairman Group's portfolio value rose 9.8% quarter-over-quarter to $140M.
Based on Fairman Group's 13F filing for Q3 2026, filed 26 Oct 2026.